Braeburn Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Braeburn Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11234
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:42
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥33,750見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥67,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥101,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Braeburn Inc (Braeburn), formerly Braeburn Pharmaceuticals Inc (Braeburn), is a biopharmaceutical company that develops medicines for the treatment of opioid addiction. The company’s lead product candidate CAM2038 is a weekly and monthly subcutaneous injection depot formulation of buprenorphine indicated for opioid use disorder (OUD). Braeburn harnesses FluidCrystal injection depot technology for developing its product portfolio. The company is funded by Wellington Management Company, Avista Capital Partners, New Leaf Venture Partners, Apple Tree Partners, Rock Springs Capital among others. Braeburn is headquartered in Plymouth Meeting, Pennsylvania, the US.

Braeburn Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Braeburn Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Braeburn Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Braeburn Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Braeburn Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Braeburn Inc, Medical Devices Deals, 2012 to YTD 2018 9
Braeburn Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Braeburn Inc, Pharmaceuticals & Healthcare, Deal Details 12
Asset Purchase 12
Braeburn Pharma Acquires Risperidone Implant from Endo Pharma 12
Venture Financing 13
Braeburn Pharma Raises USD110 Million in Mezzanine Financing 13
Braeburn Pharma Raises USD22 Million in Venture Financing 15
Braeburn Pharma Raises USD22 Million in Venture Financing 16
Braeburn Pharma Raises USD35 Million in Venture Financing 17
Braeburn Pharma Raises USD15 Million in Venture Financing 18
Braeburn Pharma Raises USD30 Million in Venture Financing 19
Braeburn Pharma Raises USD23.8 Million in Venture Financing 20
Braeburn Pharma Raises USD10 Million in Venture Financing 21
Braeburn Pharma Raises USD8.5 Million in Venture Financing 22
Braeburn Pharma Raises USD10 Million in Venture Financing 23
Licensing Agreements 24
Braeburn Pharma Enters into Licensing Agreement with Camurus 24
Knight Therapeutics Enters into Licensing Agreement with Braeburn Pharma for Probuphine 25
Camurus Expands Licensing Agreement with Braeburn Pharma 26
Braeburn Pharma Amends Licensing Agreement With Titan Pharma For Probuphine 28
Braeburn Pharma Enters into Licensing Agreement with Oncothyreon 30
Equity Offering 31
Braeburn Pharma Withdrawn IPO 31
Braeburn Pharma to Raise USD40 Million in Private Placement of Shares 33
Titan Pharma Raises USD5 Million in Private Placement of Shares 34
Braeburn Inc – Key Competitors 35
Braeburn Inc – Key Employees 36
Braeburn Inc – Locations And Subsidiaries 37
Head Office 37
Recent Developments 38
Corporate Communications 38
Jun 25, 2018: Braeburn Names Richard Malamut As Chief Medical Officer 38
Dec 12, 2017: Braeburn Pharmaceuticals Welcomes Two New Members to its Board of Directors 39
Jun 05, 2017: Braeburn Pharmaceuticals Names Michael M. Derkacz as President and CEO 40
Other Significant Developments 41
Apr 12, 2018: Braeburn Launches Brave Action 41
Appendix 42
Methodology 42
About GlobalData 42
Contact Us 42
Disclaimer 42

List of Tables
Braeburn Inc, Pharmaceuticals & Healthcare, Key Facts 2
Braeburn Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Braeburn Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Braeburn Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Braeburn Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Braeburn Inc, Medical Devices Deals, 2012 to YTD 2018 9
Braeburn Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Braeburn Pharma Acquires Risperidone Implant from Endo Pharma 12
Braeburn Pharma Raises USD110 Million in Mezzanine Financing 13
Braeburn Pharma Raises USD22 Million in Venture Financing 15
Braeburn Pharma Raises USD22 Million in Venture Financing 16
Braeburn Pharma Raises USD35 Million in Venture Financing 17
Braeburn Pharma Raises USD15 Million in Venture Financing 18
Braeburn Pharma Raises USD30 Million in Venture Financing 19
Braeburn Pharma Raises USD23.8 Million in Venture Financing 20
Braeburn Pharma Raises USD10 Million in Venture Financing 21
Braeburn Pharma Raises USD8.5 Million in Venture Financing 22
Braeburn Pharma Raises USD10 Million in Venture Financing 23
Braeburn Pharma Enters into Licensing Agreement with Camurus 24
Knight Therapeutics Enters into Licensing Agreement with Braeburn Pharma for Probuphine 25
Camurus Expands Licensing Agreement with Braeburn Pharma 26
Braeburn Pharma Amends Licensing Agreement With Titan Pharma For Probuphine 28
Braeburn Pharma Enters into Licensing Agreement with Oncothyreon 30
Braeburn Pharma Withdrawn IPO 31
Braeburn Pharma to Raise USD40 Million in Private Placement of Shares 33
Titan Pharma Raises USD5 Million in Private Placement of Shares 34
Braeburn Inc, Key Competitors 35
Braeburn Inc, Key Employees 36

List of Figures
Braeburn Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Braeburn Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Braeburn Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Braeburn Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Braeburn Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Braeburn Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Braeburn Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Braeburn Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Braeburn Inc, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Braeburn Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Aegion Corp (AEGN):企業の財務・戦略的SWOT分析
    Aegion Corp (AEGN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Wanbury Ltd (WANBURY):企業の財務・戦略的SWOT分析
    Summary Wanbury Ltd (Wanbury) is a pharmaceutical company that manufactures and sells active pharmaceutical ingredients. The company offers products such as Cpink tablet, rabiplus capsule, cdense tablets, gems, folinine softule, adtrol-plus soft gelatin capsule, cheer capsule and cheer syrup. It inc …
  • Redhall Group Plc:企業の戦略・SWOT・財務情報
    Redhall Group Plc - Strategy, SWOT and Corporate Finance Report Summary Redhall Group Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Sernova Corp (SVA):製薬・医療:M&Aディール及び事業提携情報
    Summary Sernova Corp (Sernova) is a clinical stage regenerative medicines company which develops and commercializes medical device and combination products for the treatment of chronic diseases. The company develops Cell Pouch System, an implantable medical device, which offers a natural organ-like …
  • TransCanada Corp:企業の戦略・SWOT・財務情報
    TransCanada Corp - Strategy, SWOT and Corporate Finance Report Summary TransCanada Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Banque Cantonale de Geneve Private Banking:企業の戦略・SWOT・財務情報
    Banque Cantonale de Geneve Private Banking - Strategy, SWOT and Corporate Finance Report Summary Banque Cantonale de Geneve Private Banking - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, …
  • Luitpold Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Luitpold Pharmaceuticals Inc (Luitpold Pharmaceuticals), a subsidiary of Daiichi Sankyo Co Ltd is a manufacturer and marketer of drugs and medical devices. The company provides products such as injectable parenteral medications that are used in pharmacy admixtures and nutrient solutions, cri …
  • NuVasive Inc (NUVA):医療機器:M&Aディール及び事業提携情報
    Summary NuVasive Inc (NuVasive) is a medical device company that provides minimally invasive, procedurally-integrated spine solutions. The company principally provides Maximum Access Surgery (MAS), a minimally-disruptive surgical platform. MAS platform enables surgeons to perform a range of minimall …
  • Repsol SA (REP):企業の財務・戦略的SWOT分析
    Repsol SA (REP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • PaR Systems LLC:企業の戦略的SWOT分析
    PaR Systems LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Soligenix Inc (SNGX):製薬・医療:M&Aディール及び事業提携情報
    Summary Soligenix Inc (Soligenix) is a late-stage biopharmaceutical company which focuses on the development of products for the treatment of serious inflammatory diseases and biodefense counter measures. It develops biotherapeutics for the treatment of orphan diseases such as cutaneous T-cell lymph …
  • Nature’s Sunshine Products Inc (NATR):企業の財務・戦略的SWOT分析
    Summary Nature's Sunshine Products Inc (Nature's Sunshine) is a manufacturer and marketer of nutritional and personal care products. The company’s products comprise daily essential pack, probiotics, antioxidants, enzymes, vitamins and minerals, general cleansers, fiber, meal replacement and protein, …
  • Penn National Gaming Inc:企業のM&A・事業提携・投資動向
    Penn National Gaming Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Penn National Gaming Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisiti …
  • Atmos Energy Corporation (ATO):石油・ガス:M&Aディール及び事業提携情報
    Summary Atmos Energy Corp (Atmos Energy) is a fully-regulated natural gas distributor. Together with its subsidiaries, the company delivers natural gas through regulated sales and transportation arrangements to residential, commercial, public authority and industrial customers.The company is also in …
  • TAT Technologies, Ltd.:企業の戦略・SWOT・財務情報
    TAT Technologies, Ltd. - Strategy, SWOT and Corporate Finance Report Summary TAT Technologies, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • American Bridge Company:企業の戦略・SWOT・財務分析
    American Bridge Company - Strategy, SWOT and Corporate Finance Report Summary American Bridge Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Metsa Tissue Corporation:企業の戦略的SWOT分析
    Metsa Tissue Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Ivanhoe Mines Ltd:企業のM&A・事業提携・投資動向
    Ivanhoe Mines Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Ivanhoe Mines Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), div …
  • Femasys Inc:医療機器:M&Aディール及び事業提携情報
    Summary Femasys Inc (Femasys) is a medical device company that develops and manufactures medical device solutions for women’s healthcare. The company offers non-surgical female sterilization devices, and devices for the diagnosis of infertility, and cervical cancer diagnosis. Its products include fe …
  • Sally Beauty Holdings Inc:企業の戦略・SWOT・財務分析
    Sally Beauty Holdings Inc - Strategy, SWOT and Corporate Finance Report Summary Sally Beauty Holdings Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆